ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1172

Single Cell Sequencing of Non-Lesional Non-Sun Exposed Skin from SLE Patients with Proteinuria Supports Widespread Endothelial Activation

Robert Clancy1, Evan Der2, Kemal Akat3, Anna R. Broder4, H. Michael Belmont5, Peter M. Izmirly6, Beatrice Goilav7, Thomas Tuschl3, Chaim Putterman8 and Jill P. Buyon1, 1Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3Rockefeller University, New York, NY, 4Rheumatology-Forchheimer 701N, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, 5New York University School of Medicine, New York, NY, 6Rheumatology, NYU School of Medicine, New York, NY, 7Division of Nephrology, Children's Hospital at Montefiore, Bronx, NY, 8Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: endothelial cells and skin, Lesions, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Given the widespread vasculopathy present in SLE, endothelial cell activation in the renal tubulointerstitium in lupus nephritis (LN) may be accompanied by similar activation in other tissue beds, even non-lesional skin. Faithful reflection of a relevant pathway in renal tissue by a more readily accessible compartment would be an advance. Single-cell transcriptional states as performed in this study may provide a framework for understanding how in vivo biological function emerges from complex cell ensembles. Accordingly, this study utilized single-cell RNAseq as a novel approach to identify whether non-lesional non-sun exposed skin reflects diffuse activation of the microvasculature in patients with LN.  

Methods:

Single-cell RNAseq was performed on cell suspensions prepared from  ~2 mm punch biopsies of non-lesional non sun-exposed skin from the buttocks of 5 SLE patients with proteinuria and known ISN/RPS Class and 1 healthy control.  The libraries were prepared on the Fluidigm C1 platform followed by sequencing on an Illumina HiSeq 2500. We generated 192 single-cell data sets with on average 3500 genes/cell and 50% of reads mapping to the reference genome.  The profile of differential expression analysis was used to assign in vivo cell-type compositions through unsupervised sampling and modeling of transcriptional states in single cells. Data are expressed as transcripts per million. 

Results:

Based on expression of PROCR, F2R, VWF, CD34, SERPINE1, ESAM and MCAM (CD146), assignments yielded 36 endothelial cells from 5 patients. From the two Class II subjects there were 10 single-cell transcriptomes. The other three subjects (1- Class IV,V; 1- Class V, 1-Class IV) yielded 26 single cell transcriptomes. Further consideration used evaluations of broad signatures involving the NFkB pathway (reflected by expression of SELE, ICAM1 & VCAM1) and IFNa response/Stat genes (IFI27, IFI44L, IFIH1, IFIT1, IFIT3, CXCL14 & SOCS3). The endothelial cells from patients with Class II had a significantly lower expression of NFkB-related genes compared to those with more advanced disease (4 of 10, i.e. 4 cells expressed at least one transcript and 6 none, vs 20 of 26, p<0.001). Both groups strongly expressed at least one IFNa response gene (10 of 10 vs 26 of 26).  In addition, standard lineage markers identified the major skin resident and infiltrating cell types including keratinocytes, and lymphocytes.  In contrast to the endothelial cells, these cells all displayed low expression of NFkB transcripts, independent of biopsy Class. However, IFNa responsive genes were strongly represented in all 5 patients. The skin biopsy from the healthy control showed neither NFkB nor IFNa responsive genes. 

Conclusion:

Single-cell RNAseq is feasible and informative in cell specific transcriptome analysis of fresh non-lesional skin biopsies from SLE patients with a spectrum of active renal disease. Insidious expression of endothelial activation and genes reflective of cytokine exposure support application of this novel approach to study readily accessible tissue. Insight into disease progression should facilitate earlier identification and treatment, critical to tissue survival in organs such as the kidney.


Disclosure: R. Clancy, None; E. Der, None; K. Akat, None; A. R. Broder, None; H. M. Belmont, None; P. M. Izmirly, None; B. Goilav, None; T. Tuschl, None; C. Putterman, None; J. P. Buyon, None.

To cite this abstract in AMA style:

Clancy R, Der E, Akat K, Broder AR, Belmont HM, Izmirly PM, Goilav B, Tuschl T, Putterman C, Buyon JP. Single Cell Sequencing of Non-Lesional Non-Sun Exposed Skin from SLE Patients with Proteinuria Supports Widespread Endothelial Activation [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/single-cell-sequencing-of-non-lesional-non-sun-exposed-skin-from-sle-patients-with-proteinuria-supports-widespread-endothelial-activation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-sequencing-of-non-lesional-non-sun-exposed-skin-from-sle-patients-with-proteinuria-supports-widespread-endothelial-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology